About Celtarys
Celtarys is a company based in Spain founded in 2021. Celtarys offers products and services including GPCR Ligands, Adenosine Receptors, Adrenergic Receptors, and CRO Services. Celtarys operates in a competitive market with competitors including AnalytiCon Discovery, Magellan BioScience Group, C2 Pharma, BJ Biochem and Metagreen, among others.
- Headquarter Spain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Celtarys Research
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$81.91 K (USD), Grant
Jul 01, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Celtarys
Celtarys offers a comprehensive portfolio of products and services, including GPCR Ligands, Adenosine Receptors, Adrenergic Receptors, and CRO Services.
Fluorescent ligands for high-throughput drug screening assays
Specific ligands targeting adenosine receptors in drug discovery
Ligands for adrenergic receptor studies in research applications
Custom development for drug discovery and optimization processes
People of Celtarys
Unlock access to complete
Funding Insights of Celtarys
Investors in Celtarys
Celtarys has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Celtarys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Celtarys
Investment portfolio details for Celtarys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Celtarys
Detailed financials for Celtarys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Celtarys Comparisons
Peer comparison for Celtarys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Celtarys
Celtarys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AnalytiCon Discovery, Magellan BioScience Group, C2 Pharma, BJ Biochem and Metagreen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Natural products chemistry is specialized in by AnalytiCon Discovery.
|
|
| Locked | Locked | Locked |
Identifies and develops microbial natural product leads for pharmaceutical and industrial applications
|
|
| Locked | Locked | Locked |
Manufactures and distributes active pharmaceutical ingredients and compounds worldwide.
|
|
| Locked | Locked | Locked |
Research and development services for sugar derivatives are provided.
|
|
| Locked | Locked | Locked |
Develops technologies to harness compounds from natural production.
|
Detailed competitors of Celtarys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Celtarys
Complete news archive for Celtarys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celtarys
Celtarys was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Celtarys is headquartered in Spain.
Celtarys was founded in 2021 in Spain as a biotech company focused on research. Novel chemical tools are developed and commercialized to support fluorescence-based methods in drug discovery. Fluorescent probes are designed and synthesized for various therapeutic targets, through which drug development processes are streamlined. Operations center on advancing biomedical research tools, with applications in the pharmaceutical sector across Europe.
Celtarys's top competitors include AnalytiCon Discovery, BJ Biochem and Magellan BioScience Group.
Celtarys offers GPCR Ligands, Adenosine Receptors, Adrenergic Receptors, and CRO Services.
Celtarys has 1 investor. Key investors include European Union.